Article
Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation.
Leukemia - 1 Jul 2020
Kim Rathana, Boissel Nicolas, Touzart Aurore, Leguay Thibaut, Thonier Florian, Thomas Xavier, Raffoux Emmanuel, Huguet Françoise, Villarese Patrick, Fourrage Cécile, Passini Loïc, Hunault Mathilde, Lepretre Stéphane, Chevallier Patrice, Braun Thorsten, Lhéritier Véronique, Chantepie Sylvain, Maury Sébastien, Escoffre Martine, Tavernier Emmanuelle, Chalandon Yves, Graux Carlos, Macintyre Elizabeth, Ifrah Norbert, Asnafi Vahid, Dombret Hervé, Lhermitte Ludovic
Abstract excerpt
The prognostic value of IL7-receptor pathway (IL7Rp) mutations in T-cell acute lymphoblastic leukemia (T-ALL) remains unclear. We performed a comprehensive study of 200 adult patients with T-ALL included in the GRAALL2003/2005 protocols to address the clinical significance of IL7Rp mutations. Next-generation sequencing of the IL7Rp (IL7R/JAK1/JAK3/STAT5B) revealed that IL7Rp mutations were frequent in adult T-ALL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
